Inventor · disambiguated record
Masuo Yamaoka
Also filed as: YAMAOKA MASUO
6 granted patents·5 pending applications·117 citations·filing 1996–2014
83Inventor score
Top patents by PatentIndex Score
11 records- 0193US5753664AHeterocyclic compounds, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1996·Granted May 19, 1998·78 cites·6 claims
- 0279US6573289B1Naphthalene derivatives, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1999·Granted Jun 3, 2003·23 cites·35 claims
- 0366US7067537B2Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereofTAKEDA PHARMACEUTICAL·Filed 2001·Granted Jun 27, 2006·4 cites·21 claims
- 0464US7084149B2Naphthalene derivatives, their production and useTAKEDA PHARMACEUTICAL·Filed 2003·Granted Aug 1, 2006·2 cites·27 claims
- 0563US6649643B1Imidazol-4-ylmehanols and their use as inhibitors of steroid C17-20 lyaseTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2000·Granted Nov 18, 2003·2 cites·17 claims
- 0657US6420375B1Fused ring compounds, process for producing the same and use thereofTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1998·Granted Jul 16, 2002·8 cites·19 claims
- 0754US2009169610A1Liposome PreparationYAMAZAKI NOBORU·Filed 2007·Application pending·0 cites
- 0854US2010261689A1Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapiesYAMAOKA MASUO·Filed 2008·Application pending·0 cites
- 0949US2014256693A1Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapiesTAKEDA PHARMACEUTICAL·Filed 2014·Application pending·0 cites
- 1046US2010119452A1Screening methodTAKEDA PHARMACEUTICAL·Filed 2008·Application pending·0 cites
- 1143US2009042857A1Novel PharmaceuticalYAMAOKA MASUO·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Masuo Yamaoka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →